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Abstract
Soy protein isolate (SPI) in the diet may inhibit colon tumorigenesis. We examined azoxymethane
(AOM)-induced aberrant crypt foci (ACF) in male rats in relation to lifetime, pre-weaning, or post-
weaning dietary exposure to SPI and also within the context of fetal alcohol exposure. Pregnant
Sprague Dawley rats were fed AIN-93G diets containing casein (20%, the control diet) or SPI (20%)
as the sole protein source starting on gestation day 4 (GD 4). Progeny were weaned on postnatal
day (PND) 21 to the same diet as their dams and were fed this diet until termination of the
experiment at PND 138. Rats received AOM on PND 89 and 96. Lifetime (GD 4 to PND 138)
feeding of SPI led to reduced frequency of ACF with 4 or more crypts in the distal colon. Progeny
of dams fed SPI only during pregnancy and lactation or progeny fed SPI only after weaning exhibited
similarly reduced frequency of large ACF in distal colon. Number of epithelial cells, in the distal
colon, undergoing apoptosis was unaffected by diet. SPI reduced weight gain and adiposity, but
these were not correlated with fewer numbers of large ACF. Lifetime SPI exposure similarly
inhibited development of large ACF in Sprague Dawley rats whose dams were exposed to ethanol
during pregnancy. In summary, feeding of SPI to rat dams during pregnancy and lactation suppresses
numbers of large ACF in their progeny, implying a long-term or permanent change elicited by the
maternal diet. Moreover, results support the use of ACF as an intermediate endpoint for
elucidating effects of SPI and its biochemical constituents in colon cancer prevention in rats.
Background
Colorectal cancer is the third leading cause of cancer-
related deaths in the U.S.; an estimated 147,500 new cases
of this disease will have occurred in the U.S. during 2003
[1]. Globally, this cancer is a significant health problem as
its incidence is increasing with the burgeoning of the aged
population and with 'Westernization' of diets. Most
recently, the cancer incidence rates for the ascending
colon have increased whereas those for all other colon
subsites (transverse, descending, sigmoid and rectum)
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have stabilized or declined slightly [2,3]. The incidence of
colorectal cancer, like that for breast and prostate cancers,
is lower in Asian than American and European popula-
tions [4]. This has implied a possible protective effect of
the Asian diet and of soy foods in particular, on colon can-
cer incidence. Epidemiological studies are generally sup-
portive of the postulated protection against colorectal
cancer incidence by consumption of soy components and
soy foods [4-6]. However, these studies were not designed
to decipher possible effects of lifetime vs. developmental
stage-specific dietary exposure to soy. In this regard, soy
consumption during adolescence may preferentially
reduce subsequent risks for breast cancer in later adults
[7,8].
Soy foods are the main dietary sources of isoflavones,
which are implicated in cancer prevention [4,5,9]. Soy
foods are a source of other potentially cancer-preventive
substances as well, including saponins, protease inhibi-
tors, and other bio-active peptides and proteins [9-13].
However, the literature concerning effects of pure isofla-
vones or processed soy products (soy flour, soy protein) in
animal models of colon cancer is mixed. Many investiga-
tors utilized the rat and administered a chemical carcino-
gen, either dimethylhydrazine (DMH) or azoxymethane
(AOM). Both agents rapidly induce formation of aberrant
crypt foci (ACF) and subsequent development of colon
adenomas and adenocarcinomas. Investigators have uti-
lized ACF number and type, tumor number and type, or
the combination, as endpoints to examine effects of soy
and soy constituents on colon cancer. Dietary genistein
(the predominant soy isoflavone) was inhibitory to ACF
formation in AOM-treated rats [14,15]. Order of protec-
tion (measured as ACF number) was genistein > defatted
soy flour > full-fat soy flakes > soy concentrate (isofla-
vone-depleted) [16]. Similarly, soy bean saponins inhib-
ited ACF incidence in AOM-treated mice at 14 weeks post-
initiation [11]. However, in the study of Gee et al., [17],
feeding of isoflavone-containing soy protein isolate or of
genistein (with casein) for 7 days prior to DMH treatment
(and switching to casein diet thereafter) actually pro-
moted ACF numbers in the distal colon; whereas, feeding
of these same diets for 42 days immediately after carcino-
gen administration had no effect. Davies et al. [18] formu-
lated diets to mimic the Western type (i.e., high fat, low
calcium) diet supplemented with low or high isoflavone-
containing soy protein isolates, and ACF and tumors were
subsequently measured in AOM-rats. Increased numbers
of small ACFs were found at 12 weeks, post-carcinogen
administration in the isoflavone-enhanced group. There-
fore, there is a lack of consensus for effects of soy or soy
components on chemically-induced ACFs in rodents and
the underlying basis of these discrepancies is unknown.
The picture is also unclear when tumors rather than ACFs
are used as the end point. In an early study, soybean pro-
tein did not differ from beef protein in terms of relative
numbers of colon tumors in DMH-treated rats [19]. Defat-
ted soybean meal was not protective in the same model
[20]. However, we previously reported the protection
afforded by lifetime-feeding of a soy protein isolate,
against colon carcinoma in AOM-treated male Sprague
Dawley rats [21]. Dietary genistein, on the other hand,
had no effect on colon adenocarcinoma incidence or mul-
tiplicity of invasive colon carcinoma, yet actually
increased noninvasive and total adenocarcinoma multi-
plicity [22]. In contrast, soy protein isolates with two lev-
els of total isoflavones did not elicit differences in colon
tumorigenesis in the Min mouse model of intestinal can-
cer [23]. However, feeding of a high molecular weight
insoluble fraction from proteinase-treated soybean pro-
tein isolate suppressed colon tumor numbers in rats
[24,25].
The above studies used diets made with soy protein iso-
lates or soy components prepared in different ways and
supplemented to varying levels. Furthermore, diets usu-
ally were fed just prior to or concurrent with the chemical
carcinogen in order to focus on initiation or progression
of tumorigenesis. Some studies did not account for the
fact that commercial rodent diets can include soy protein;
moreover there is significant maternal-fetal transfer of iso-
flavones in rats fed soy-containing diets [26]. Thus, pre-
exposure to soy constituents during various stages of an
animal's life cycle potentially complicates interpretation
of the reported results. With the single exception of the
study from our group [21], no studies examined the
effects of lifetime (including gestational) exposure, by
feeding of soy or purified soy components, on colon
tumor or ACF incidence. In view of the significant use of
soy-based infant formulae, which accounts for greater
than 25% of the infant formula currently sold in the
United States [9,27], it is important to examine potential
SPI effects on colon tissue pre-disposition to cancer. Here,
we utilize male Sprague Dawley rats fed AIN-96G diets
formulated with casein or SPI to examine dietary effects
on AOM-induced ACF incidence and multiplicity. We also
examine effects of dietary SPI at pre- and post-weaning vs.
lifetime consumption. Lastly, we confirm the SPI effect on
colon ACF biogenesis in a second model, namely, AOM-
treated rats whose dams were exposed to ethanol during
their pregnancy.
Methods
Solid Diets
Diets contained either casein or SPI as the sole protein
source (200 g/Kg diet) and their formulation has been
previously described [21,28]. Casein (ALACID 741) was
from New Zealand Milk Products (North America) Inc.Journal of Carcinogenesis 2004, 3:14 http://www.carcinogenesis.com/content/3/1/14
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(Santa Rosa, CA). SPI was a gift from DuPont Protein
Technologies (St. Louis, MO). Total isoflavone content
was 3.70–3.98 mg/g protein and total aglycone equiva-
lents were 2.13–2.32 mg/g protein for the SPI. Corn oil
replaced soybean oil and essential amino acid content was
maintained at levels for that of the AIN-93G diet [29].
Diets were prepared by Harlan Teklad (Madison, WI).
Animals
Animals were housed in an AAALAC-approved animal
facility at the Arkansas Children's Hospital Research Insti-
tute; animal use protocols were approved by the Univer-
sity of Arkansas for Medical Sciences Institutional Animal
Care and Use Committee. Animals were housed in poly-
carbonate cages and allowed ad libitum access to diet and
water. Animal rooms had constant humidity and a 12-h
light-dark cycle.
Expt. I. Lifetime, Pre-weaning and Post-weaning Diets
Pregnant Sprague Dawley dams from Harlan, Inc. (Indi-
anapolis, IN) were received at gestation day (GD) 4 and
immediately assigned in random fashion to casein or SPI
diet. At postnatal day (PND) 2, each litter was culled to 5
males and 5 females (females were used in an unrelated
experiment). At weaning, animals were divided into four
diet groups: lifetime (GD 4 to PND 138) casein, n = 25;
lifetime SPI, n = 25; casein to SPI, n = 25; and SPI to
casein, n = 25. Diet switchovers were performed at PND
21 and all rats were given AOM on PND 89 and 96. Rats
were injected subcutaneously with AOM (Midwest
Research Institute) in saline, 15 mg/kg body weight. Ani-
mals were weighed weekly from birth and were eutha-
nized at PND 138 for ACF determination or TUNEL assay.
Expt. II. Intra-gastric Infusion of Ethanol-containing CAS 
and SPI Liquid Diets during Pregnancy
Pregnant rats at GD 5 were surgically implanted with an
intra-gastric cannula as previously described [30]. Dams
were fed casein plus ethanol (n = 5) or SPI plus ethanol (n
= 7) by total enteral nutrition (TEN) from GD 6 – GD 19
[30]. TEN diets were isocaloric and met NRC require-
ments for normal pregnancy [30]. Amounts of casein
hydrolysate (MPH 955; New Zealand Milk Products) and
SPI (Soy Clinical Blend IB1.2; total isoflavone content was
3.98 mg/g protein, total aglycone equivalents were 2.32
mg/g protein; DuPont Protein Technologies) added to liq-
uid TEN diets were 31.5 and 31 g/l, respectively. Ethanol
was infused at increasing amounts to reach a maximum of
10 g/Kg body weight. At GD 19, ethanol was no longer
fed, however, the TEN diets were infused until parturition
and simultaneously, corresponding solid diet was added
to cages. After parturition, only water was infused (25 ml/
23 h) and solid diets were continued ad libitum. At PND 2,
each litter was culled to 5 males and 5 females (females
were used in an unrelated experiment). Progeny were
weaned to the same diet as for their dam. Number of male
progeny allocated to casein and SPI diets was 24 and 29,
respectively.
Visualization of ACF
Fifteen animals of each diet group in Experiments I and II
were used for ACF determination. Colon contents were
removed by flushing from the cecal end with ~20 ml of
PBS via syringe. Each colon was slid onto a 2 ml pipette
and was fixed in this position for 10 min in 10% neutral
buffered-formalin. The colon was opened, laid flat and
placed between sheets of labeled filter paper in fixative in
the cold. Tissue was removed from formalin, divided into
proximal and distal halves, and stained in 0.2% methyl-
ene blue in PBS for 5–7 min or until the tissue had a uni-
form blue appearance. Tissues were rinsed with PBS for ~1
min and stored in 0.4% formalin-PBS at 4°C. Aberrant
crypt foci were viewed immediately after staining using a
Nikon AMZ800 stereoscope at 40× magnification with
side illumination. Proximal and distal colon halves were
reviewed along their entire lengths and all ACF were
counted. Aberrant crypt foci were categorized according to
crypt complexity (1, 2, 3, 4, 5, etc., crypts per ACF). All
colons were scored in blinded fashion by a single
observer. Colons that failed to yield useable data due to
poor fixation and/or staining were excluded from statisti-
cal analysis.
TUNEL
Colons not used for ACF determination (i.e., whole-
mount fixation) were divided into proximal and distal
halves and the midpoints of each half taken for fixation.
Tissue was fixed in 10% neutral buffered-formalin, proc-
essed through a graded series of ethanol and xylene
washes, embedded in paraffin, 4 µm sections obtained,
and these were subjected to TUNEL assay. The TdT-FragEL
DNA Fragmentation Detection kit (Oncogene Research
Products, San Diego, CA) was used for this purpose.
Approximately 200 crypt columns were examined from
each of 4–5 animals in each diet group.
Adiposity
Body composition data were obtained on anesthetized
rats by dual energy x-ray absorptiometry (DXA) using a
Hologic QDR 4500A instrument (Bedford, MA). Five rats
(at 33 days post-AOM treatment) were randomly chosen
from casein and SPI diet groups (Expt. I) for DXA analysis.
Percentage of global fat (% fat) was determined.
Statistical Analyses
The ACF endpoints were discrete variables (numbers of
crypts, numbers of ACF, etc.) and hence were not nor-
mally distributed. We took the natural logarithm of all
data points since log-transformed values were less skewed
than the original data and more amenable to analysis.Journal of Carcinogenesis 2004, 3:14 http://www.carcinogenesis.com/content/3/1/14
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However, for simplicity, figures and tables present the
original (not log-transformed) data. To examine diet
effects, we used the SAS System's (SAS, SAS Institute, Inc.,
Cary, NC) PROC GLM procedure. Unpaired t tests were
also used to examine differences between proximal and
distal colon for several endpoints. Incidence of large ACF
(with 5 or more crypts per focus) was analyzed using
Fisher's Exact Test (SigmaStat for Windows Version 2.03,
SPSS Inc.). For all analyses, a P value less than 0.05 was
considered significant, while 0.05 < P < 0.1 was deemed
marginal. Body weights and body fat content were com-
pared by t-test (SigmaStat).
Results
Effects of Lifetime Consumption of Casein and SPI on 
Colonic ACF Frequency
In casein-fed animals, the distal half of the colon had 2–3
fold more ACF of each size class than did the proximal
half (Fig. 1). In rats lifetime-fed casein or SPI, differences
in ACF content were observed for distal colon (Table 1).
SPI feeding led to fewer numbers of ACF with 4, 5 and >5
crypts and as a consequence, a reduced overall ACF crypt
multiplicity for distal colon. Crypts/focus was slightly
reduced (by ~8%) by SPI in the proximal colon (P = 0.01).
SPI did not differ from the casein group in the frequencies
of ACF containing 1, 2 or 3 aberrant crypts in either colon
region.
Dietary Switchovers at Weaning and Subsequent ACF 
Formation
To examine the possibility that dietary exposure to SPI
over the period encompassing fetal and neonatal develop-
ment could mimic effects of lifetime SPI, we performed
diet switchovers of Sprague Dawley rats at weaning and
surveyed their colons six weeks after AOM administration,
relative to animal's lifetime-fed SPI diet concurrently. The
ACF occurrence in proximal and distal colon of Sprague Dawley rats (n = 12) lifetime-fed casein Figure 1
ACF occurrence in proximal and distal colon of Sprague Dawley rats (n = 12) lifetime-fed casein. Shown are means ± SEM of 
ACF (per rat) containing: 1, 2, 3, 4, 5 or greater than 5 crypts (5+) per ACF; crypt multiplicity (number of aberrant crypts/
focus); total number of ACF; and total number of aberrant crypts (no. ACF × crypts/focus). P values indicate all statistically sig-
nificant differences between proximal and distal colon.
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opposite switchover, from casein to SPI at weaning, was
carried out in parallel to examine effects of SPI, from post-
weaning through to adulthood.
ACF frequency for each diet switchover generally mim-
icked that for lifetime SPI (Fig. 2). Analysis for the relative
incidence rather than the mean number (per animal) of
the largest ACF (those containing 5 or >5 crypts) for all
diet groups is shown in Table 2. These data further sup-
port a protective role for dietary SPI (lifetime, CAS/SPI or
SPI/CAS regimens) on appearance of large ACF.
Apoptosis
At six weeks, post-AOM, there were no observable differ-
ences in the relative apoptotic state of total colonic epithe-
lium in distal colons of CAS, SPI, CAS/SPI and SPI/CAS
groups (Table 3). However, the upper third crypt region of
the CAS/SPI group had ~2-fold more apoptotic cells than
did the lifetime SPI or SPI/CAS groups.
Growth and Body Composition
SPI-fed animals weighed less than corresponding casein-
fed counterparts (Fig. 3). The body weight differences
between the casein and SPI groups were evident as early as
PND 10 postnatal and prior to weaning (Fig. 3). Adminis-
tration of AOM resulted in temporary cessation of growth
and a small amount of weight loss in all groups (Fig. 3);
however after a short lag period, all animals resumed
growth. Growth curves of casein/SPI and SPI/casein
switch-over groups were intermediate between those for
lifetime casein and SPI groups (data not shown). Analysis
of body composition (at 33 days post-AOM treatment) by
DXA revealed significant differences in global % fat
between groups (CAS > SPI, difference of ~3.3 percentage
points; Fig. 4) and this somewhat mimicked the observed
final differences in body weight. Regression analysis did
not identify any significant associations between final
body weight and proximal or distal ACF numbers or
crypts/focus (Fig. 5 and data not shown).
ACF in AOM-treated Adult Rats Previously Exposed to 
Ethanol as Fetuses
We confirmed the inhibitory effect of SPI on occurrence of
large ACF in a second model, namely, progeny of Sprague
Dawley dams that received ethanol + casein or ethanol +
SPI by total enteral nutrition (TEN) during gestation and
which were weaned to the same diet as their dams (para-
digm shown in Fig. 6). We chose this model since we were
interested in examining how diet, in combination with
ethanol, might affect ACF distribution in progeny. As is
evident from Fig. 7, SPI inhibited the occurrence of large
ACF relative to the casein diet in animals exposed to
ethanol as fetuses. Unlike the results from Expt. I. how-
ever, SPI-fed animals exhibited reduced ACF numbers in
both proximal and distal colons and these ACF now
included those with 3 aberrant crypts (Fig. 7). Moreover,
there was an increased occurrence of ACF with three or
more crypts in the proximal colons of casein-fed rats in
Expt. II vs. those in Expt. I. In the absence of a true no-eth-
anol control for Expt. II, we cannot make any final conclu-
sions about the specific effect of fetal alcohol exposure on
ACF frequency in the later adult stage. However, these
data do suggest that fetal alcohol exposure favors the
development of large ACF which was inhibited by SPI in
the diet.
Discussion
The objectives of this study were to: a) elucidate effects of
SPI on colon ACF frequency in rat models, b) study effects
of dietary SPI on somatic growth and adiposity in view of
their potential interactions with colon ACF incidence, c)
examine developmental and lifetime 'exposures' to
Table 1: Effect of diet on ACF distribution by colon region*
Proximal Colon Distal Colon
CAS SPI CAS SPI
ACF – 1 Crypt 5.50 ± 1.03 6.55 ± 1.35 10.58 ± 1.77 12.55 ± 2.45
ACF – 2 Crypts 9.92 ± 2.28 8.65 ± 1.61 18.33 ± 2.36 16.27 ± 2.81
ACF – 3 Crypts 4.67 ± 0.96 5.18 ± 1.17 11.42 ± 1.57 8.18 ± 1.91
ACF – 4 Crypts 1.50 ± 0.40 a 0.82 ± 0.38 5.83 ± 0.99 b 2.45 ± 0.73
ACF – 5 Crypts 0.42 ± 0.26 0.27 ± 0.20 1.67 ± 0.33 c 0.64 ± 0.47
ACF – 5+ Crypts 0.08 ± 0.08 0.09 ± 0.09 0.42 ± 0.19 d 0.09 ± 0.09
Crypts/Focus 2.17 ± 0.05 a 2.00 ± 0.09 2.38 ± 0.07 c 2.02 ± 0.04
ACF Total 22.08 ± 4.29 21.54 ± 4.08 48.25 ± 5.98 40.18 ± 6.93
Crypt Total 47.92 ± 9.47 44.55 ± 8.98 115.67 ± 14.83 e 83.18 ± 15.55
* CAS, n = 12; SPI, n = 11; shown are means ± SEM per animal for ACF of differing sizes; 5+ = no. ACFs containing 6 or more aberrant crypts; crypt 
total = sum of ACF × crypts/focus.
aP = 0.01, bP = 0.005, cP = 0.001, dP = 0.091, eP = 0.044; P values for differences between diets within each region; SAS.Journal of Carcinogenesis 2004, 3:14 http://www.carcinogenesis.com/content/3/1/14
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Frequency distribution of ACF in Sprague Dawley rats lifetime-fed SPI or switched, at weaning, from CAS to SPI or from SPI to  CAS Figure 2
Frequency distribution of ACF in Sprague Dawley rats lifetime-fed SPI or switched, at weaning, from CAS to SPI or from SPI to 
CAS. Analysis of proximal and distal colon halves is shown. Shown are means ± SEM, per rat, of ACF containing: 1, 2, 3, 4, 5 or 
greater than 5 crypts (5+) per ACF; crypt multiplicity (number of aberrant crypts/focus); total number of ACF; and total 
number of aberrant crypts. P value indicates the only statistically significant difference between switchover diets and SPI.
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dietary SPI and consequent effects on ACF indices, and d)
correlate ACF data with our previously published colon
tumor data obtained with animals lifetime fed SPI [21].
ACF may provide a more time- and cost-effective means to
study SPI effects on colon cancer prevention in animal
models and we sought to further explore this possibility in
the current study. We report that SPI reduced the inci-
dence of the largest size classes of ACF in AOM-treated,
adult Sprague Dawley male rats and, regardless of whether
SPI was fed during GD 4 – PND 21, only after PND 21, or
from GD 4 to PND 138. This effect of SPI also was mani-
fested in animals whose dams were exposed to ethanol
during pregnancy; thereby suggesting the generality of the
SPI effect.
ACF have been identified on the colon luminal surface in
rats and mice treated with chemical carcinogens (AOM,
DMH, and NMU) and in humans with and without overt
colon carcinoma [31,32]. AOM stimulates both prolifera-
tion and apoptosis in the colonic mucosa [33] and ACF
are thought to be the earliest observable pre-neoplastic
lesions to arise in this tissue [34,35]. The validity of ACF
as an intermediate biomarker for colon cancer is however,
controversial. Larger multi-cryptal ACF are generally cor-
related with tumor incidence in rodents and humans
[32,36-42]. Feeding a Western-type diet can induce ACF as
well as adenomas and carcinomas in normal mouse colon
[43]. Thiagarajan et al. [16] reported a trend for diets that
promoted ACF numbers to also increase colon tumor
numbers. In other studies, however, DMH or AOM
induced the occurrence of adenomas and adenocarcino-
mas in the distal colon which were correlated with ACF
number; whereas the proximal colon developed signet-
ring type carcinomas which were not correlated with ACF
[44-46]. Moreover, there may be discrete subset(s) of ACF,
not easily recognized by the standard assay, that progress
to microadenomas and which are characterized by
increased dysplasia, altered oncoprotein and tumor sup-
pressor expression and/or genomic instability [37,47-51].
Previously, we reported that Sprague Dawley rats, lifetime
fed casein-AIN-93G diet had a 50% incidence, whereas
those fed SPI-AIN-93 G diet had a 12% incidence of colon
tumors, at 40 weeks post-AOM [21]. In our previous
study, tumor incidence was similarly reduced for proxi-
mal and distal regions by SPI. However, in the present
study, we found that SPI reduced crypt multiplicity and
frequency of large ACF (those containing 4 or more
crypts) mainly in the distal colon, which at six weeks post-
Table 2: Relative incidence of largest ACFs (5 or >5 Crypts/ACF)*
CAS SPI CAS/SPI SPI/CAS
% rats with ACF(s) containing 5 crypts
Proximal 25 18 0 38
Distal 83 18a 57 54
Entire 83 36b 57 69
% rats with ACF(s) containing >5 crypts
P r o x i m a l 8900
Distal 33 9 0 15
Entire 42 18 0 15
* CAS, n = 12; SPI, n = 11; CAS/SPI, n = 7; SPI/CAS, n = 13.
a, bCompared to CAS: aP = 0.003; bP = 0.036; Fisher's Exact Test.
Table 3: Effect of diet regimen on TUNEL positive cells in the distal colona
CASb SPI CAS/SPI SPI/CAS
Totalc 18.0 ± 2.55 13.8 ± 3.20 24.6 ± 5.80 16.0 ± 3.89
Upperd, e 6.8 ± 3.02 3.2 ± 1.07 11.4 ± 2.02 2.25 ± 0.48
Middle 4.6 ± 0.93 3.2 ± 1.02 9.2 ± 4.68 9.5 ± 3.12
Lower 6.8 ± 2.63 7.2 ± 1.93 4.4 ± 1.29 4.75 ± 0.75
aCAS, n = 5; SPI, n = 5; CAS/SPI, n = 5; SPI/CAS, n = 4 animals; PND 138.
bMean values are expressed as the number of positive cells per 200 crypt columns ± SEM.
cData are for entire crypts.
dData represent upper one-third, middle one-third or lower one-third regions of crypts, respectively.
eOverall diet effect (P = 0.024); CAS/SPI > SPI and >SPI/CAS, P < 0.05; One-way ANOVA and Student-Newman-Keuls method.Journal of Carcinogenesis 2004, 3:14 http://www.carcinogenesis.com/content/3/1/14
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Feeding of casein or SPI to pregnant dams and their progeny elicits differential growth rates Figure 3
Feeding of casein or SPI to pregnant dams and their progeny elicits differential growth rates. Top panel shows body weight 
(mean ± SEM) gain in relation to postnatal day (PND) and time of administration of azoxymethane (AOM) for progeny of 
Sprague Dawley dams. Bottom panel shows divergence in body weights during early postnatal development. P values indicating 
differences between CAS and SPI groups (t-test) are shown in lower panel.
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AOM had more ACF of each size than did the proximal
region. Therefore, the present ACF data are in general con-
cordance with our previous tumor data but only for the
distal colon. The basis for the discordance of ACF and
tumor data for the proximal colon is unknown but is in
general agreement with other studies showing correla-
tions of larger ACFs with distal but not proximal colon
tumors [44-46].
A diet switching paradigm examined whether the suppres-
sive effect of SPI on larger ACF required lifetime exposure
or could be mimicked with a shorter developmental
period of SPI feeding. We also questioned if 'protective'
effects could be transferred maternally to the offspring.
The results of this experiment are of interest for a number
of reasons. The observation that SPI elicited reduced
growth by day 10, postnatal, may point to a 'maternal
effect' of SPI, during gestation or lactation or both that is
transmitted to progeny to affect their growth. The exact
nature of this effect awaits further clarification. Both diet
switchovers generally mimicked the effects of lifetime SPI
on ACF incidence, although the casein/SPI regimen
appeared to be slightly more effective than the SPI/casein
dietary treatment in this regard. We therefore surmise that
SPI can manifest long lasting effects on ACF incidence and
that at least some of these effects can be transmitted to the
offspring through feeding of SPI to pregnant and/or lactat-
ing dams.
Obesity is considered by some to be a promoter of onco-
genesis in rat models of chemically induced colon cancer
[52,53] and of colon cancer in humans [54]. Positive
interactions of soyfoods with increasing body mass index
to reduce breast cancer risk in humans have been
Dietary protein type influences body fat content Figure 4
Dietary protein type influences body fat content. DXA was performed on five animals per group (CAS: casein; SPI: soy protein 
isolate) at 33 days after the second AOM administration. Means (±SEM) are statistically different for the two diets.
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Lack of association of final body weight with ACF size Figure 5
Lack of association of final body weight with ACF size.
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suggested [55]. In the current study, DXA analysis identi-
fied differences in global % fat that could account for the
differences between final body weights of casein and SPI
animals; although we examined only a limited number of
animals in this regard. However, we were unable to find
any statistically significant associations of final body
weight and ACF for the diet groups. Therefore, our results
do not indicate any obvious positive relationship between
relative fat content and ACF incidence.
Kállay et al. [56] observed that the feeding of soy protein
isolate selectively suppressed or enhanced colonic gene
expression (relative to casein). Their work as well as the
present results underscores the need for further elucidat-
ing direct and indirect actions of dietary SPI and its pro-
tein and non-protein constituents on colonic mucosal
growth and differentiation during development through
to adulthood. The somewhat conflicting literature regard-
ing effects of soy on colon carcinoma in the rat may derive
in part from differences in the nature of the dietary casein
and SPI used, and the relative developmental timing of
SPI feeding. Studies that used commercial diets contain-
ing soy constituents for propagation of rat colonies for
subsequent experiments may also have been confounded
by pre-exposure to soy. It may be important to standardize
this developmental soy exposure in future studies so as to
reach consensus on the colon cancer-preventive actions of
soy and its constituent(s).
Conclusions
SPI inhibited the development of large ACF, some of
which may be tumor precursors. Feeding of SPI to rat
dams during pregnancy and lactation led to a suppression
in numbers of large ACF in their progeny, implying a
long-term or permanent anti-carcinogenic effect elicited
by the SPI-based diet. Body weight and body composition
were differentially affected by soy protein isolate or casein
in the diet. ACF may be a valid intermediate endpoint for
elucidating effects of SPI and its biochemical constituents
in tumor prevention in the colons of Sprague Dawley rats.
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Experimental design used for evaluation of diet effects on ACF in progeny of dams exposed to ethanol during pregnancy Figure 6
Experimental design used for evaluation of diet effects on ACF in progeny of dams exposed to ethanol during pregnancy.
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Frequency distribution of ACF in rat progeny lifetime fed casein (n = 10) or SPI (n = 14) and whose dams were exposed to eth- anol during pregnancy (Fig. 6) Figure 7
Frequency distribution of ACF in rat progeny lifetime fed casein (n = 10) or SPI (n = 14) and whose dams were exposed to eth-
anol during pregnancy (Fig. 6). Analysis of proximal and distal colon halves is presented. Shown are mean ± SEM, per rat, of 
ACF containing: 1, 2, 3, 4, 5 or greater than 5 crypts (5+) per ACF; crypt multiplicity (number of aberrant crypts/focus); total 
number of ACF; and total number of aberrant crypts. P values indicate statistically significant differences between diets.
0
2
4
6
8
10
12
CAS
SPI
N
u
m
b
e
r
 
o
f
 
A
C
F
 
o
r
 
C
r
y
p
t
s
/
F
o
c
u
s Proximal Colon
Crypts/Focus
Crypts
TotalA CFs
Total crypts 1       2        3       4       5   5+
p=.031
*
p=.054
*
p=.029
p=.049
*
0
15
30
45
60
75
90
0
2
4
6
8
10
12
14
CAS
SPI
N
u
m
b
e
r
 
o
f
 
A
C
F
 
o
r
 
C
r
y
p
t
s
/
F
o
c
u
s
Distal Colon
0
20
40
60
80
100
120
140
Crypts/Focus
Crypts
Total ACFs
Total crypts 1       2        3       4       5       5+
*
p=.033
p=.09
p=.041
p=.048
p=.045
* *
*
p=.062Journal of Carcinogenesis 2004, 3:14 http://www.carcinogenesis.com/content/3/1/14
Page 13 of 14
(page number not for citation purposes)
manipulations. FAS conceived of the study, participated
in its design, interpreted the data and prepared the
manuscript. All authors read, modified and approved the
final manuscript.
Acknowledgements
We thank Matthew Ferguson, Renea Eason, Leon Chatman, Renee Till, 
Michael Velarde, Xin Shi, Jamie Badeaux, Misty Reeves, Chris Curtis, 
Tammy Dallari, Alexis Bussell, Trae Pittman and Kim Hale for assistance 
with animals, diets and tissue collection. We acknowledge Mark Robinette 
and Pam Treadaway for helping with data management, analysis and pres-
entation. Thanks to Drs. Rosalia C.M. Simmen, Martin J.J. Ronis, Shanmu-
gam Nagarajan, Rick Helm and Ling He for helpful discussions and for 
critically reading the manuscript. We also thank Dr. Daniel D. Gallaher and 
Cindy Gallaher (University of Minnesota) for sharing their protocol for 
whole-mount fixation of colons. This work was supported by USDA CRIS 
6251-5100-002-06S to the Arkansas Children's Nutrition Center and by 
NIH 2RO1AA008645. This research was performed, in part, using com-
pound(s) provided by the National Cancer Institute's Chemical Carcinogen 
Reference Standards Repository operated under contract by Midwest 
Research Institute, NO. N02-CB-07008.
References
1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ: Cancer
statistics, 2003. CA Cancer J Clin 2003, 53:5-26.
2. Ries LA, Wingo PA, Miller DS, Howe HL, Weir HK, Rosenberg HM,
Vernon SW, Cronin K, Edwards BK: The annual report to the
nation on the status of cancer, 1973–1997, with a special sec-
tion on colorectal cancer. Cancer 2000, 88:2398-2424.
3. Howe HL, Wingo PA, Thun MJ, Ries LA, Rosenberg HM, Feigal EG,
Edwards BK: Annual report to the nation on the status of can-
cer (1973 through 1998), featuring cancers with recent
increasing trends. J Natl Cancer Inst 2001, 93:824-842.
4. Toyomura K, Kono S: Soybeans, Soy Foods, Isoflavones and
Risk of Colorectal Cancer: a Review of Experimental and
Epidemiological Data. Asian Pac J Cancer Prev 2002, 3:125-132.
5. Bennink MR: Dietary soy reduces colon carcinogenesis in
human and rats. Soy and colon cancer. Adv Exp Med Biol 2001,
492:11-17.
6. Spector D, Anthony M, Alexander D, Arab L: Soy consumption
and colorectal cancer. Nutr Cancer 2003, 47:1-12.
7. Shu XO, Jin F, Dai Q, Wen W, Potter JD, Kushi LH, Ruan Z, Gao YT,
Zheng W: Soyfood intake during adolescence and subsequent
risk of breast cancer among Chinese women. Cancer Epidemiol
Biomarkers Prev 2001, 10:483-488.
8. Wu AH, Wan P, Hankin J, Tseng CC, Yu MC, Pike MC: Adolescent
and adult soy intake and risk of breast cancer in Asian-Amer-
icans. Carcinogenesis 2002, 23:1491-1496.
9. Badger TM, Ronis MJ, Hakkak R, Rowlands JC, Korourian S: The
health consequences of early soy consumption. J Nutr 2002,
132:559S-565S.
10. Weed HG, McGandy RB, Kennedy AR: Protection against
dimethylhydrazine-induced adenomatous tumors of the
mouse colon by the dietary addition of an extract of soy-
beans containing the Bowman-Birk protease inhibitor. Car-
cinogenesis 1985, 6:1239-1241.
11. Koratkar R, Rao AV: Effect of soya bean saponins on
azoxymethane-induced preneoplastic lesions in the colon of
mice. Nutr Cancer 1997, 27:206-209.
12. Logvinova AV, Foehr MW, Pemberton PA, Khazalpour KM, Funk-
Archuleta MA, Bathurst IC, Tomei LD: Soy-derived antiapoptotic
fractions protect gastrointestinal epithelium from damage
caused by methotrexate treatment in the rat. Nutr Cancer
1999, 33:33-39.
13. Galvez AF, Chen N, Macasieb J, de Lumen BO: Chemopreventive
property of a soybean peptide (lunasin) that binds to
deacetylated histones and inhibits acetylation.  Cancer Res
2001, 61:7473-7478.
14. Pereira MA, Barnes LH, Rassman VL, Kelloff GV, Steele VE: Use of
azoxymethane-induced foci of aberrant crypts in rat colon to
identify potential cancer chemopreventive agents. Carcinogen-
esis 1994, 15:1049-1054.
15. Steele VE, Pereira MA, Sigman CC, Kelloff GJ: Cancer chemopre-
vention agent development strategies for genistein. J Nutr
1995, 125(3 Suppl):713S-716S.
16. Thiagarajan DG, Bennink MR, Bourquin LD, Kavas FA: Prevention
of precancerous colonic lesions in rats by soy flakes, soy
flour, genistein, and calcium.  Am J Clin Nutr 1998, 68(6
Suppl):1394S-1399S.
17. Gee JM, Noteborn HP, Polley AC, Johnson IT: Increased induction
of aberrant crypt foci by 1,2-dimethylhydrazine in rats fed
diets containing purified genistein or genistein-rich soya
protein. Carcinogenesis 2000, 21:2255-2259.
18. Davies MJ, Bowey EA, Adlercreutz H, Rowland IR, Rumsby PC:
Effects of soy or rye supplementation of high-fat diets on
colon tumour development in azoxymethane-treated rats.
Carcinogenesis 1990, 20:927-931.
19. Reddy BS, Narisawa T, Weisburger JH: Effect of a diet with high
levels of protein and fat on colon carcinogenesis in F344 rats
treated with 1,2-dimethylhydrazine.  J Natl Cancer Inst 1976,
57:567-569.
20. McIntosh GH, Le Leu RK: The influence of dietary proteins on
colon cancer risk. Nutr Res 2001, 21:1053-1066.
21. Hakkak R, Korourian S, Ronis MJ, Johnston JM, Badger TM: Soy pro-
tein isolate consumption protects against azoxymethane-
induced colon tumors in male rats. Cancer Lett 2001, 166:27-32.
22. Rao CV, Wang CX, Simi B, Lubet R, Kelloff G, Steele V, Reddy BS:
Enhancement of experimental colon cancer by genistein.
Cancer Res 1997, 57:3717-3722.
23. Sorensen IK, Kristiansen E, Mortensen A, Nicolaisen GM, Wijnands
JA, van Kranen HJ, van Kreijl CF: The effect of soy isoflavones on
the development of intestinal neoplasia in ApcMin mouse.
Cancer Lett 1998, 130:217-225.
24. Azuma N, Suda H, Iwasaki H, Kanamoto R, Iwami K: Soybean curd
refuse alleviates experimental tumorigenesis in rat colon.
Biosci Biotechnol Biochem 1999, 63:2256-2258.
25. Azuma N, Suda H, Iwasaki H, Yamagata N, Saeki T, Kanamoto R,
Iwami K: Antitumorigenic effects of several food proteins in a
rat model with colon cancer and their reverse correlation
with plasma bile acid concentration. J Nutr Sci Vitaminol (Tokyo)
2000, 46:91-96.
26. Brown NM, Setchell KD: Animal models impacted by phytoes-
trogens in commercial chow: implications for pathways influ-
enced by hormones. Lab Invest 2001, 81:735-747.
27. Mendez MA, Anthony MS, Arab L: Soy-based formulae and infant
growth and development: a review. J Nutr 2002, 132:2127-2130.
28. Hakkak R, Korourian S, Shelnutt SR, Lensing S, Ronis MJ, Badger TM:
Diets containing whey proteins or soy protein isolate protect
against 7,12-dimethylbenz(a)anthracene-induced mammary
tumors in female rats.  Cancer Epidemiol Biomarkers Prev 2000,
9:113-117.
29. Reeves PG, Nielsen FH, Fahey GC Jr: AIN-93 purified diets for
laboratory rodents: final report of the American Institute of
Nutrition ad hoc writing committee on the reformulation of
the AIN-76A rodent diet. J Nutr 1993, 123:1939-1951.
30. Badger TM, Ronis MJ, Lumpkin CK, Valentine CR, Shahare M, Irby D,
Huang J, Mercado C, Thomas P, Ingelman-Sundberg M, Crouch J:
Effects of chronic ethanol on growth hormone secretion and
hepatic cytochrome P450 isozymes of the rat. J Pharmacol Exp
Ther 1993, 264:438-47.
31. Nascimbeni R, Villanacci V, Mariani PP, Di Betta E, Ghirardi M,
Donato F, Salerni B: Aberrant crypt foci in the human colon:
frequency and histologic patterns in patients with colorectal
cancer or diverticular disease.  Am J Surg Pathol 1999,
23:1256-1263.
32. Roncucci L, Pedroni M, Vaccina F, Benatti P, Marzona L, De Pol A:
Aberrant crypt foci in colorectal carcinogenesis. Cell and
crypt dynamics. Cell Prolif 2000, 33:1-18.
33. Kishimoto Y, Morisawa T, Hosoda A, Shiota G, Kawasaki H, Haseg-
awa J: Molecular changes in the early stage of colon carcino-
genesis in rats treated with azoxymethane. J Exp Clin Cancer Res
2002, 21:203-211.
34. Siu IM, Robinson DR, Schwartz S, Kung HJ, Pretlow TG, Petersen RB,
Pretlow TP: The identification of monoclonality in human
aberrant crypt foci. Cancer Res 1999, 59:63-66.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Journal of Carcinogenesis 2004, 3:14 http://www.carcinogenesis.com/content/3/1/14
Page 14 of 14
(page number not for citation purposes)
35. Bird RP, Good CK: The significance of aberrant crypt foci in
understanding the pathogenesis of colon cancer. Toxicol Lett
2000, 112:395-402.
36. Pretlow TP, O'Riordan MA, Somich GA, Amini SB, Pretlow TG:
Aberrant crypts correlate with tumor incidence in F344 rats
treated with azoxymethane and phytate. Carcinogenesis 1992,
13:1509-1512.
37. Shpitz B, Bomstein Y, Kariv N, Shalev M, Buklan G, Bernheim J: Che-
mopreventive effect of aspirin on growth of aberrant crypt
foci in rats. Int J Colorectal Dis 1998, 13:169-172.
38. Takayama T, Katsuki S, Takahashi Y, Ohi M, Nojiri S, Sakamaki S, Kato
J, Kogawa K, Miyake H, Niitsu Y: Aberrant crypt foci of the colon
as precursors of adenoma and cancer.  N Engl J Med 1998,
339:1277-1284.
39. Delker DA, Wang QS, Papanikolaou A, Whiteley HE, Rosenberg
DW:  Quantitative assessment of azoxymethane-induced
aberrant crypt foci in inbred mice.  Exp Mol Pathol 1999,
65:141-149.
40. Wijnands MV, Schoterman HC, Bruijntjes JB, Hollanders VM, Wout-
ersen RA: Effect of dietary galacto-oligosaccharides on
azoxymethane-induced aberrant crypt foci and colorectal
cancer in Fischer 344 rats. Carcinogenesis 2001, 22:127-132.
41. Corpet DE, Tache S: Most effective colon cancer chemopre-
ventive agents in rats: a systematic review of aberrant crypt
foci and tumor data, ranked by potency. Nutr Cancer 2002,
43:1-21.
42. Rodrigues MA, Silva LA, Salvadori DM, De Camargo JL, Montenegro
MR:  Aberrant crypt foci and colon cancer: comparison
between a short- and medium-term bioassay for colon car-
cinogenesis using dimethylhydrazine in Wistar rats. Braz J
Med Biol Res 2002, 35:351-355.
43. Newmark HL, Yang K, Lipkin M, Kopelovich L, Liu Y, Fan K, Shinozaki
H: A Western-style diet induces benign and malignant neo-
plasms in the colon of normal C57Bl/6 mice. Carcinogenesis
2001, 22:1871-1875.
44. Park HS, Goodlad RA, Wright NA: The incidence of aberrant
crypt foci and colonic carcinoma in dimethylhydrazine-
treated rats varies in a site-specific manner and depends on
tumor histology. Cancer Res  1997, 57:4507-4510.
45. Davies MJ, Rumsby PC: Long-term analysis of colonic aberrant
crypt formation after treatment of Sprague-Dawley rats
with azoxymethane. Teratog Carcinog Mutagen 1998, 18:183-197.
46. Ghirardi M, Nascimbeni R, Villanacci V, Fontana MG, Di Betta E,
Salerni B: Azoxymethane-induced aberrant crypt foci and
colorectal tumors in F344 rats: sequential analysis of growth.
Eur Surg Res 1999, 31:272-280.
47. Bouzourene H, Chaubert P, Seelentag W, Bosman FT, Saraga E:
Aberrant crypt foci in patients with neoplastic and nonneo-
plastic colonic disease. Hum Pathol 1999, 30:66-71.
48. Takahashi M, Mutoh M, Kawamori T, Sugimura T, Wakabayashi K:
Altered expression of beta-catenin, inducible nitric oxide
synthase and cyclooxygenase-2 in azoxymethane-induced
rat colon carcinogenesis. Carcinogenesis 2000, 21:1319-1327.
49. Yamada Y, Yoshimi N, Hirose Y, Kawabata K, Matsunaga K, Shimizu
M, Hara A, Mori H: Frequent beta-catenin gene mutations and
accumulations of the protein in the putative preneoplastic
lesions lacking macroscopic aberrant crypt foci appearance,
in rat colon carcinogenesis. Cancer Res 2000, 60:3323-3327.
50. Luo L, Li B, Pretlow TP: DNA alterations in human aberrant
crypt foci and colon cancers by random primed polymerase
chain reaction. Cancer Res 2003, 63:6166-6169.
51. Hirose Y, Kuno T, Yamada Y, Sakata K, Katayama M, Yoshida K, Qiao
Z, Hata K, Yoshimi N, Mori H: Azoxymethane-induced beta-cat-
enin-accumulated crypts in colonic mucosa of rodents as an
intermediate biomarker for colon carcinogenesis. Carcinogen-
esis 2003, 24:107-11.
52. Weber RV, Stein DE, Scholes J, Kral JG: Obesity potentiates
AOM-induced colon cancer. Dig Dis Sci 2000, 45:890-895.
53. Lee WM, Lu S, Medline A, Archer MC: Susceptibility of lean and
obese Zucker rats to tumorigenesis induced by N-methyl-N-
nitrosourea. Cancer Lett 2001, 162:155-160.
54. Bird CL, Frankl HD, Lee ER, Haile RW: Obesity, weight gain, large
weight changes, and adenomatous polyps of the left colon
and rectum. Am J Epidemiol 1998, 147:670-680.
55. Dai Q, Shu XO, Jin F, Potter JD, Kushi LH, Teas J, Gao YT, Zheng W:
Population-based case-control study of soyfood intake and
breast cancer risk in Shanghai. Br J Cancer 2001, 85:372-378.
56. Kállay E, Adlercreutz H, Farhan H, Lechner D, Bajna E, Gerdenitsch
W, Campbell M, Cross HS: Phytoestrogens regulate vitamin D
metabolism in the mouse colon: relevance for colon tumor
prevention and therapy.  J Nutr 2002, 132(11
Suppl):3490S-3493S.